• Activity INFORMATION

  Overview

  Direct oral anticoagulants (DOACs) are recognized by guidelines as first-line options for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalular atrial fibrillation.  The use of DOACs is wide-spread, and it is challenging to ensure patient safety as each agent has slightly different pharmacokinetic considerations with their use.  This program will address safety and efficacy with each agent, initial recommendations for dosing and adjustments based on renal considerations, drug interactions, and age and weight.  Common risk factors for bleeding will be identified as well as options in support of the management of bleeding, if it should occur, are proposed. 
  

  Handouts

  • Slide Document :   20177H01_2pp.pdf Download

  • Slide Document :   20177H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify appropriate modifications of direct acting anticoagulants such as dose adjustments or optimization of therapy in patients at risk for diminished efficacy or bleeding.

  Determine appropriate individualized treatment for patients based upon current literature and evidence based guidelines.

  Differentiate among direct acting anticoagulants available for the treatment of non-valvular atrial fibrillation and venous thromboembolism.

  Nurse

  Identify appropriate modifications of direct acting anticoagulants such as dose adjustments or optimization of therapy in patients at risk for diminished efficacy or bleeding.

  Differentiate among direct acting anticoagulants available for the treatment of non-valvular atrial fibrillation and venous thromboembolism.

  Determine appropriate individualized treatment for patients based upon current literature and evidence based guidelines.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-763353

  Universal Activity Number

  Pharmacist 0798-0000-20-177-H01-P
  Nurse 0798-0000-20-177-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Shannon  Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC Professor of Clinical Pharmacy, University of Tennessee College of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).